Bullish
Humana stock hits 52-week high at 381.2 USD By Investing.com
Humana Inc. (NYSE: HUM) stock has reached a new 52-week high of $381.12, reflecting a 59% return over the past year and substantial gains year-to-date...
Bullish
Humana Inc. (NYSE: HUM) stock has reached a new 52-week high of $381.12, reflecting a 59% return over the past year and substantial gains year-to-date...
Neutral
Humana Inc. (NYSE:HUM) stock reached a 52-week high, trading at $381.12, reflecting a 59% return over the past year. The healthcare giant also announc...
Neutral
Humana (HUM) is shifting its focus from membership growth to earnings improvement, aiming to restore insurance margins to over 3% by 2028. The company...
Bearish
A federal watchdog report found that the three largest Medicare Advantage insurers—UnitedHealth Group, Humana, and CVS Health—denied post-hospital car...
Humana (HUM) is demonstrating early signs of recovery after two years of elevated medical costs, with a focus now on improving earnings and restoring ...
Bearish
Schubert Jonckheer & Kolbe LLP is investigating Humana Inc. (NYSE: HUM) regarding potential false and misleading statements about the company's exposu...
Humana Inc. (NYSE: HUM) is scheduled to release its second quarter 2026 financial results and prepared management remarks on July 29, 2026, at 6:00 a....
Neutral
Humana has secured a significant statewide contract to manage care for Illinois's Medicaid population, marking a strategic expansion into the governme...
Bullish
Humana Inc. has secured a statewide Medicaid contract in Illinois for its HealthChoice Illinois program, expanding its services across all 102 countie...
Bearish
Kahn Swick & Foti, LLC (KSF) is continuing its investigation into Humana Inc. (NYSE: HUM) concerning potential breaches of fiduciary duties by its off...
Bearish
A new OIG report reveals that the three largest Medicare Advantage insurers—CVS Health, Humana, and UnitedHealth Group—deny inpatient rehab requests a...
Bearish
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Humana Inc. (NYSE:HUM) securities who purchased prior ...
Bullish
Humana is selling its stake in Gentiva for $900 million. This sale is linked to Humana's 2021 acquisition strategy and comes as the insurer faces incr...
Neutral
Humana has agreed to sell its interest in Gentiva, a home health, palliative, and hospice care provider, for approximately $900 million to an undisclo...
Bullish
Cantor Fitzgerald has reiterated an Overweight rating and a $264.00 price target for Humana Inc. after the company secured a new Illinois Medicaid con...
Evercore ISI has increased its price target for Humana (HUM) to $370 from $250, while maintaining an "In Line" rating for the stock. This adjustment c...
Neutral
Humana and CenterWell employees donated over $1.4 million to 1,650 nonprofit organizations in 24 hours during the Humana Foundation’s annual Double Ma...
Bullish
Humana and CenterWell employees donated over $1.4 million to 1,650 nonprofits in 24 hours during the Humana Foundation’s annual Double Match Day in Ap...
Bullish
Humana Inc. stock has reached a new 52-week high of $361.21, significantly above its previous high of $356.01, reflecting a 55.47% increase over the p...
Bullish
Humana Inc. (NYSE: HUM) stock has hit a new 52-week high of $361.21, trading just 1% above its previous high of $356.01, with a market capitalization ...